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Abstract
This article is part of a series written for people responsible for making decisions about health policies and
programmes and for those who support these decision makers.
Policymakers and those supporting them often find themselves in situations that spur them on to
work out how best to define a problem. These situations may range from being asked an awkward
or challenging question in the legislature, through to finding a problem highlighted on the front page
of a newspaper. The motivations for policymakers wanting to clarify a problem are diverse. These
may range from deciding whether to pay serious attention to a particular problem that others claim
is important, through to wondering how to convince others to agree that a problem is important.
Debates and struggles over how to define a problem are a critically important part of the
policymaking process. The outcome of these debates and struggles will influence whether and, in
part, how policymakers take action to address a problem. Efforts at problem clarification that are
informed by an appreciation of concurrent developments are more likely to generate actions.
These concurrent developments can relate to policy and programme options (e.g. the publication
of a report demonstrating the effectiveness of a particular option) or to political events (e.g. the
appointment of a new Minister of Health with a personal interest in a particular issue). In this article,
we suggest questions that can be used to guide those involved in identifying a problem and
characterising its features. These are: 1. What is the problem? 2. How did the problem come to
attention and has this process influenced the prospect of it being addressed? 3. What indicators can
be used, or collected, to establish the magnitude of the problem and to measure progress in
addressing it? 4. What comparisons can be made to establish the magnitude of the problem and to
measure progress in addressing it? 5. How can the problem be framed (or described) in a way that
will motivate different groups?
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About STP
This article is part of a series written for people responsible for
making decisions about health policies and programmes and for
those who support these decision makers. The series is intended
to help such people ensure that their decisions are well-informed
by the best available research evidence. The SUPPORT tools
and the ways in which they can be used are described in more
detail in the Introduction to this series [1]. A glossary for the
entire series is attached to each article (see Additional File 1).
Links to Spanish, Portuguese, French and Chinese translations
of this series can be found on the SUPPORT website (http://
www.support-collaboration.org). Feedback about how to
improve the tools in this series is welcome and should be sent to:
STP@nokc.no.
Scenarios
Scenario 1: You are a senior civil servant and have been asked
to submit a briefing note to the Minister about a health system
problem in which she has a personal interest, namely that many
of her constituents and family members say that they can’t find
a primary healthcare physician. You are concerned about
whether the current draft of the briefing note prepared by a jun-
ior policy analyst does justice to the problem.
Scenario 2: You work in the Ministry of Health and are prepar-
ing a briefing note about a health system problem. All that you
have been told is that the problem is about many citizens not
having access to primary healthcare providers and services.
Scenario 3: You work in an independent unit that supports the
Ministry of Health in its use of research evidence in policymak-
ing and are preparing a policy brief for the Ministry of Health
on barriers to accessing primary healthcare. You want guidance
on how to clarify the problem in a systematic and comprehen-
sive way.
Background
For policymakers (Scenario 1), this article suggests a
number of questions that they might ask their staff to con-
sider when preparing a briefing note about a problem. For
those who support policymakers (Scenarios 2 and 3), this
article suggests a number of questions to guide the clarifi-
cation of a problem based on the best available local and
global evidence. This article is the first of three articles
about clarifying evidence needs (see also Articles 5 and 6
[2,3]). Figure 1 outlines the processes involved in clarify-
ing these needs.
Policymakers and those supporting them often find them-
selves in situations in which they need to decide how best
to define a problem. They may have:
• Identified a problem through an explicit priority-set-
ting process (the focus of Article 3) [4]
￿ Read about a problem in a report from a national
statistical agency or from an independent researcher
￿ Been asked a tough question about a problem in the
legislature or by someone living in their constituency
￿ Found a problem highlighted on the front page of a
daily newspaper, or
￿ Identified a problem through their personal experi-
ence of a health system
Some of these situations lend themselves to the proactive
assessment of a problem, or what some might call an issue
or challenge. But most typically they place policymakers
in a reactive mode.
The motivation for policymakers to clarify a problem may
be informed by a consideration of:
￿ Whether to pay serious attention to a particular
problem that others assert is important
￿ What factors contribute to a problem
￿ How to measure the magnitude of a problem
(whether it is getting better or worse, and whether it is
responding to particular policies or programmes)
￿ How to convince others to agree that a problem is
important (or that a favoured way forward is the opti-
mal one given how it addresses a particular problem),
or
￿ How to address misperceptions or manage expecta-
tions among those who (erroneously, in the eyes of
the policymakers) see the problem as important
Debates and struggles over how to define a problem are a
critically important part of the policymaking process
[5,6]. The outcome of these debates and struggles will
influence whether (and, in part, how) policymakers take
action to address a problem.
Problems may come to light through:
￿ A focusing event
￿ A change in an indicator, or
￿ Feedback from the operation of a current policy or
programme [7]
Focusing events are very common in the health sector
because poor decision making may lead to extreme andHealth Research Policy and Systems 2009, 7(Suppl 1):S4 http://www.health-policy-systems.com/content/7/S1/S4
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often high-profile events such as illness and death. An
example of a focusing event would be extensive newspa-
per coverage over a number of consecutive days of the pro-
vision of counterfeit prescription drugs and the deaths
resulting from their use. A change in an indicator, though
less dramatic, can also bring a problem to attention, par-
ticularly if it is a large change or it receives significant
attention in a report or media release. A national statistical
agency, for instance, may release a report that shows that
nurses’ pay varies widely across a country and that this is
contributing to nursing shortages in certain provinces. Or
a problem may come to light through feedback from the
operation of a current policy or programme. Informal
feedback from a programme manager in charge of a pro-
vincial waiting-time reduction initiative might, for exam-
ple, highlight the fact that the programme is failing to
meet its target for wait-time reductions due to resource
limitations.
However, not all problems that are brought to attention
are deemed worthy of government action. A problem can
be defined as warranting government action by:
￿ Comparing current conditions with values related to
a ‘more ideal’ state of affairs
￿ Comparing performance with other jurisdictions,
and
￿ Framing a subject in a different way (e.g. describing
a problem as an impediment to achieve a national pri-
ority) [7]
Politicians from different political parties will reflect dif-
ferent values and interpretations related to what consti-
tutes a ‘more ideal’ state of affairs. A Minister of Health
might regard the performance of their own country’s
health system favourably relative to another in a neigh-
bouring country. But he or she might not do so when it is
compared less favourably to other but equally appropriate
international examples. Similarly, a cabinet may decide to
take action if a particular problem is defined in terms of a
lack of patient choice among healthcare providers (given
that this could potentially become a source of frustration
for voters), but not if a problem is defined in terms of a
Clarifying evidence needs Figure 1
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lack of interest on the part of physicians in joining clinics
that use collaborative practice models (this issue might be
perceived by them as being too far removed from the con-
cerns of voters).
Efforts to clarify problems are more likely to result in
action if they:
￿ Reflect an awareness of concurrent developments
related to policy and programme options (e.g. the
publication of a report demonstrating the effective-
ness of a particular option), and
￿ Are influenced by concurrent political events (such
as the appointment of a new Minister of Health who
may have a personal interest in a particular issue) [7]
If a problem is not defined in a way that ‘fits well’ with
what are perceived to be viable options, or if it does not fit
with broader political events, it is very unlikely to reach a
decision agenda. An option can be deemed to be a viable
solution if it is technically feasible, fits with dominant val-
ues and the public’s current mood, and is acceptable both
in terms of budget workability and likely political support
or opposition [7]. Relevant political events can include
swings in the public mood, changes in levels of support or
opposition from interest groups, and changes to the gov-
erning party or prevailing legislative coalition [7].
Questions to consider
The following questions can guide how to identify a prob-
lem and characterise its features:
1. What is the problem?
2. How did the problem come to attention and has
this process influenced the prospect of it being
addressed?
3. What indicators can be used or collected to establish
the magnitude of the problem and to measure
progress in addressing it?
4. What comparisons can be made to establish the
magnitude of the problem and to measure progress in
addressing it?
5. How can a problem be framed (or described) in a
way that will motivate different groups?
1. What is the problem?
A problem may relate to one or more of the following:
￿ A risk factor, disease or condition
￿ The programmes, services or drugs currently being
used to address a risk factor, disease or condition
￿ The current health system arrangements within
which programmes, services and drugs are provided,
or
￿ The current degree of implementation of an agreed
upon course of action (e.g. a policy or guideline)
The prevalence of a risk factor or the burden of a disease
or condition in a province or country (e.g. incidence rate,
prevalence rate, mortality rate) may constitute a problem.
But more often, such issues are the manifestation of a
problem: their cause is the real problem that needs to be
addressed. The problem may instead lie with the pro-
gramme or service, or relate specifically to the suitability
of a drug that is currently being used to address a risk fac-
tor, disease or condition. Ineffective programmes, services
or drugs may, for example, be in use to prevent or treat the
risk factor, disease or condition.
Alternatively, a problem may be rooted in current health
system arrangements within which programmes, services
and drugs are provided. Potential problems may lie with
governance arrangements/structures. These can include:
￿ Who has policy (e.g. regulatory), organisational,
commercial and professional authority and accounta-
bility over particular programmes
￿ The services and drugs or the parts of the health sys-
tem within which the programmes are located
￿ The services and drugs provided
￿ How authority is discharged, and
￿ How people who exercise authority are held
accountable
Potential problems may also be rooted in financial
arrangements. Such arrangements may affect who
finances (i.e. who pays for) particular programmes, serv-
ices and drugs and the parts of the health system within
which these are provided, or how organisations are
funded to deliver them. It may also relate to how profes-
sionals are remunerated to provide programmes, services
or drugs, whether patients/consumers are offered incen-
tives to use them, and how resources are allocated to
them. Further, problems may be linked to current delivery
arrangements. These may include: who is targeted by par-
ticular programmes, services and drugs, who they reach
(or who accesses and uses them), who provides them and
how, where they are they provided, what information andHealth Research Policy and Systems 2009, 7(Suppl 1):S4 http://www.health-policy-systems.com/content/7/S1/S4
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communication technology is used to provided them, and
what safety and quality systems are provided. The taxon-
omy of governance, financial and delivery arrangements is
addressed further in Article 7 in this series [8].
Finally, a problem may be rooted in the degree of imple-
mentation of an agreed course of action about a pro-
gramme, service or drug, or else an agreed course of action
about the health system arrangements within which these
are provided. A problem, for example, may already have
been defined and a policy introduced to address it, but the
policy may not yet have been translated into action. In
this instance, one approach to identifying the problem is
to identify potential barriers to implementation at one or
more of four levels:
1. The healthcare recipient and citizen level (e.g. citi-
zens are unaware that they can access a programme,
service or drug free of charge)
2. The healthcare provider level (e.g. health workers
do not fully adhere to national policies and guide-
lines)
3. The organisational level (e.g. organisations do not
manage the performance of their staff), and
4. The system level (e.g. policies are not enforced).
The identification of barriers to implementation is the
focus of Article 6 in this series [3].
Table 1: Clarifying the problem underpinning the lack of widespread use of the recommended malaria treatment
Members of the Evidence-Informed Policy Networks (EVIPNet) in ten sub-Saharan African countries identified the problem of the lack of 
widespread use of the recommended artemisinin-based combination therapy (ACT) to treat malaria in their respective countries. The following 
framework of four questions (and relevant sources of data and research evidence) [11] was used to clarify this problem:
• Does the problem relate to a risk factor, disease or condition?
 Incidence of (and death rates from) uncomplicated falciparum malaria, by age (including separately for infants), sex (including separately for 
pregnant women and lactating women), HIV status, malnutrition status, and socio-economic status
• Does the problem relate to a programme, service or drug currently being used to address a risk factor, disease or condition?
 Cure rates for, and drug resistance (or reduced drug sensitivity) to, ACT and other anti-malarial drugs, as well as the side effects and costs 
of the drugs
 The views and experiences of patients about particular anti-malarial drugs
• Does the problem relate to the current health system arrangements within which programmes, services and drugs are provided?
 Governance arrangements
– Regulations about which ACT and other anti-malarial drugs (i.e. drugs, dosage regimes, and packaging) can be registered/licensed for 
sale, how counterfeit or substandard drugs are safeguarded against, how patents for them and profits arising from them are handled, how 
they can be marketed, who can prescribe them and how, and who can sell or dispense them and how
– National treatment guidelines and/or the national malaria control policy about the first-line (and second-line) drug therapy 
recommended for uncomplicated falciparum malaria, as well as their dosage regimes/packaging, targeting for particular populations, and 
targeting for areas with particular characteristics
– National essential drugs list, particularly the list of anti-malarial drugs
 Financial arrangements
– Drug and dispensing fees for first-line drug therapy (and for ACT if this is not the first-line therapy) for uncomplicated falciparum 
malaria, including any subsidies for particular populations, remuneration arrangements for health works prescribing and dispensing ACT
– The views and experiences of patients about fees and subsidies and about financial incentives to promote adherence
 Delivery arrangements
– Access rates for first-line drug therapy 
(and for ACT if this is not first-line therapy) for uncomplicated falciparum malaria (i.e. who has access to someone who can dispense drug 
therapy)
– Coverage rates for first-line drug therapy 
(and for ACT if this is not first-line therapy) for uncomplicated falciparum malaria (i.e. who is dispensed which drug)
– Treatment patterns for uncomplicated falciparum malaria 
(i.e. who dispenses what, when, where and how, including whether treatment is part of the Integrated Management of Childhood Illness or 
other ‘horizontal’ programmes)
– Adherence patterns for the treatment of uncomplicated falciparum malaria (i.e. who takes what, when, where and how)
– Arrangements for surveillance, pharmacovigilance and the diagnosis and treatment of atypical cases
– The views and experiences of patients about particular providers (or delivery arrangements more generally)
• Does the problem relate to the current degree of implementation of an agreed-upon course of action?
 For example, regulations can only help to address a problem if they are acted upon throughout the health system. Regulations may exist 
about the registration/licensure, marketing, prescribing and dispending of ACT and other anti-malarial drugs. However, if the regulations are not 
enforced, there may be many counterfeit or substandard drugs in circulation, false statements may be made in drug advertisements, and 
untrained individuals may be prescribing or dispending ACT
The EVIPNet teams all concluded that the problem could be related to a risk factor, disease or condition, the programmes, services or drugs 
currently being used, the current health system arrangements and, in some cases, the current degree of implementation of an agreed-upon course 
of action. This had important implications for which options were considered appropriate to address this multi-faceted problem.Health Research Policy and Systems 2009, 7(Suppl 1):S4 http://www.health-policy-systems.com/content/7/S1/S4
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Policymakers and those who support them need to deter-
mine the causes of a problem. These problems may be
related to: one or more of a risk factors; a disease or con-
dition; the programmes, services or drugs currently being
used; the current health system arrangements; or the cur-
rent degree of implementation of an agreed upon course
of action. Doing so can be an iterative process. What at
first glance may appear to be a seemingly unrelated issue,
such as disincentives to manage chronic disease proac-
tively in primary healthcare, may actually be the very
problem that needs attention. Table 1 illustrates how this
simple framework can be used to clarify a problem, using
malaria treatment in sub-Saharan Africa as an example.
Policymakers and those supporting them could gain addi-
tional insights into this component of problem clarifica-
tion from the fields of complexity theory, complex
adaptive systems, and soft systems methodology. Exam-
ples of relevant resources are provided at the end of this
article.
2. How did the problem come to attention and has this 
process influenced the prospect of it being addressed?
Identifying a problem is often only the beginning of the
process. Typically, a great deal of work will still need to be
done in order to clarify a problem in a way that confirms
whether or not there is a need to address it. If there is a
need, it will also be necessary to build the support
required to address it. Understanding how a problem first
came to attention can be an important initial step in the
process of clarification. As outlined in the Background sec-
tion in this article, problems typically come to light
through:
￿ A focusing event
￿ A change in an indicator, or
￿ Feedback from the operation of current policies and
programmes
Table 2: Clarifying the problem underpinning high rates of medication error
Questions 2-5 which were discussed earlier in this article can be used to clarify a problem once it has been related to one or more of the following: 
a risk factor, disease or condition, the programmes, services or drugs currently being used, the current health system arrangements and the current 
degree of implementation of an agreed upon course of action. Consider the following example of the problem of high rates of medication error:
• How did the problem come to attention and has this process influenced the prospect of it being addressed?
 The problem of medical error may come to attention through a focusing event (e.g. a child dies because a doctor prescribes the wrong 
drug dosage), a change in an indicator (e.g. there is a dramatic increase in the number of reported errors in a given month) or feedback from the 
operation of current policies and programmes 
(e.g. an evaluation report identifies more types of medication errors than have been routinely measured)
 An evaluation report may identify that one possible factor contributing to a problem is the lack of clear boundaries of the scope of practice 
between doctors, nurses and pharmacists, which makes accountability for prescribing, dispensing, administration and chart documentation 
unclear
 The same report may propose that the problem be turned into a statement of purpose that can be used to engage a diverse array of 
stakeholders. For example, policymakers may prefer to speak about how their country will become a leader in patient safety, rather than 
referring to current patient safety problems
• What indicators can be used or collected to establish the magnitude of the problem and to measure progress in addressing it?
 Policymakers may identify that no indicators are currently being measured accurately at the national level but that they are interested in 
starting to accurately measure both the number of medication error reports per quarter and the number of ‘near misses’ per quarter. Collecting 
such data would allow them to set a target level for the indicator
• What comparisons can be made in order to establish the magnitude of the problem and to measure progress in addressing it?
 Policymakers may identify that they would like to make four types of comparisons:
– Comparisons over time within the country
– Comparisons to other appropriate comparator countries
– Comparisons against a target to be set as part of a national patient safety strategy
– Comparisons against what a national consumer association has said it would like to see
 Ideally a search for administrative database studies or community surveys would allow the policymakers to identify at least some existing 
research evidence and allow them to make immediate comparisons
• How can a problem be framed (or described) in a way that will motivate different groups?
 Policymakers may find that:
– Pharmacists respond to the language used to describe a medication error
– Consumer groups respond to a stated purpose of achieving, for example, a 50% reduction in medication errors
– Regulators engage when the lack of clear boundaries between the scope of practice of healthcare providers is discussed as an 
important feature of the problem
– Hospital staff may respond positively when told of a plan to collect an indicator that identifies under-reporting in a way does not 
penalise units or departments who support full disclosure
– Hospital executives may engage most fully when comparisons are made among their facilities
 Ideally a search for qualitative studies would allow the policymakers to grasp the different meanings that different groups attach to a 
problem Health Research Policy and Systems 2009, 7(Suppl 1):S4 http://www.health-policy-systems.com/content/7/S1/S4
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Key policymakers may (or may not) agree whether a prob-
lem warrants attention at the early stages of the problem-
clarification process. Table 2 illustrates how the question
discussed here in this sub-section (together with three
additional questions) can be used to clarify a problem
once it has been related to one or more of: a risk factor,
disease or condition; the programmes, services or drugs
currently being used; the current health system arrange-
ments; or the current degree of implementation of an
agreed upon course of action.
If key policymakers do agree that a problem warrants
attention and that they want to stake out a claim for what
they would like to achieve in addressing the problem (e.g.
through a statement of purpose or a goal), this will often
leave little time to clarify the problem accurately. Before
long, it may be necessary to move on to the specifics of
considering how the options should be framed.
It is possible though that a focusing event could, on closer
examination, turn out to be a significant aberration rather
than reflecting a widespread problem. Similarly, an indi-
cator may be found to have been poorly measured or not
adjusted for seasonal variation. Or an internal report
about the operation of current policies and programmes
may, when read more closely, contain significant errors of
interpretation. It may also be the case that policymakers
erroneously link a problem to programmes, services or
drugs currently being used when, in reality, the actual
problem may lie elsewhere.
Alternatively, key policymakers may quickly decide that a
problem does not warrant attention. They may focus on
addressing misperceptions or managing expectations
among those who first brought the problem to attention.
In the interim, those supporting such policymakers may
conduct a preliminary review and conclude that the prob-
lem is significant. In this case key policymakers will be left
with the difficult task of having to make an argument for
re-opening an issue that has been effectively closed – per-
haps even in a highly visible way.
3. What indicators can be used or collected to establish the 
magnitude of the problem and to measure progress in 
addressing it?
Depending on how a problem first comes to attention, it
may or may not be necessary to examine closely which
indicators related to a problem are currently being meas-
ured (or can and should be measured) accurately. If, for
example, a problem comes to attention through a change
in an indicator that is already known to be highly reliable,
giving further attention to other indicators may not be
needed. On the other hand, if a problem comes to atten-
tion through a focusing event, further work would be nec-
essary. In such cases:
￿ Community surveys and vital registries are examples
of good sources of indicators about a risk factor, dis-
ease or condition
￿ Healthcare administrative data (or what are some-
times called health management information sys-
tems), monitoring and evaluation data, community
surveys, and healthcare provider surveys can be good
sources of indicators about the programmes, services
and drugs currently being used
￿ Legislation, regulation, policies, drug formularies,
and policymaker surveys can be good sources of indi-
cators about governance arrangements
￿ Health expenditure surveys and healthcare provider
surveys can be good sources of indicators about finan-
cial arrangements
￿ Healthcare administrative data can be good sources
of indicators about delivery arrangements, and
￿ Community surveys and healthcare provider sur-
veys, as well as healthcare administrative data, can be
good sources of indicators about the current degree of
implementation of an agreed upon course of action
Disaggregated data, such as data by ethnicity/culture, gen-
der or socio-economic status, can often be particularly
helpful in clarifying whether a problem is widespread or
particularly pronounced in some groups. Article 11 in this
series addresses how to find and use local evidence, and
Article 10 describes a categorisation scheme for groups
which could be considered when incorporating equity-
based approaches within the process of problem clarifica-
tion [9,10].
4. What comparisons can be made to establish the 
magnitude of the problem and to measure progress in 
addressing it?
While indicators can provide policymakers with some
sense of the magnitude of a particular problem, implicit
or explicit comparisons are what truly establish whether a
problem is big or small, whether it is getting better or
worse, or whether it appears amenable to change. At least
four key types of comparisons can be made:
￿  Comparisons over time within a country: can help to
establish whether a problem is getting better or worse.
If corrective actions have already been taken, such
comparisons can help to determine whether a prob-
lem appears amenable to change
￿  Comparisons between countries and other appropriate
comparators (where the data are comparable): can helpHealth Research Policy and Systems 2009, 7(Suppl 1):S4 http://www.health-policy-systems.com/content/7/S1/S4
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to establish whether a problem is big or small and
what targets could be achievable, and help to mobilise
support for addressing a problem
￿  Comparisons against plans: (e.g. national targets and
the Millennium Development Goals) can help to
mobilise support for addressing a problem, and
￿  Comparisons against what policymakers and/or stake-
holders predicted or wanted: can also help to mobilise
support for reaching goals
While clarifying a problem relies extensively on local data,
research evidence can often provide comparisons that
have been conducted in a systematic and transparent way.
Healthcare administrative database studies and commu-
nity surveys, for example, which are often published in
research literature, can help to clarify a problem and
appropriate targets and mobilise support. Such studies
can be highly useful to policymakers in addressing mis-
perceptions or managing expectations. They can also be
used to develop or refine a statement of purpose. For
example, policymakers may want to change the trajectory
of an existing indicator or measure a new indicator in
ways that permit comparisons. Article 11 in this series
provides approaches to finding and using local evidence
[9]. Table 3 also provides tips for finding healthcare
administrative database studies and community surveys.
5. How can a problem be framed (or described) in a way 
that will motivate different groups?
How a given problem is categorised can have important
consequences for the way groups may respond. Framing a
problem in new or alternative ways is likely to result in the
issues resonating in different ways among different
groups. Canada, for example, has framed the field of study
related to the social determinants of health most neutrally
by referring to it as ‘population health’. In contrast, in the
United States, the same field is often referred to as ‘dispar-
ities in health’ – a term that conveys the existence of dif-
ferences but not necessarily unfairness. In the United
Kingdom, the term ‘inequalities in health’ is commonly
used. This term seems explicitly to convey unfairness, and
it only gained political traction when a new governing
party was elected in the 1990s with a goal of reducing
unfairness within health and other sectors. Some groups
may respond more actively to a negatively framed prob-
lem statement (e.g. “Our country has the highest infant
mortality rate in the region”) while others may respond
better to a positively framed statement of purpose (e.g.
“Our country will, within five years, achieve the national
health goals related to infant mortality”).
Some groups may rally around issues related to a particu-
lar disease or condition (e.g. rapidly rising rates of cardio-
vascular disease). Others may rally around one or more
risk factors (e.g. smoking, diet, exercise or housing and
working conditions). Even groups with a similar focus
may be attracted to different indicators related to the same
problem. Some may be motivated more by ‘hard’ indica-
tors such as mortality. But others may be motivated by
Table 3: Finding research evidence about a problem
While much of the task of problem clarification involves finding and using local evidence (the subject of Article 11 in this series), published 
administrative database studies and community surveys can provide insights about comparisons [9]. Qualitative studies can also provide insight into 
alternative framings for a problem.
The first set of steps involved in finding such studies includes:
• Drawing up a list of words or phrases that capture the problem (e.g. medication error, scope of practice), synonyms for each problem and factor 
(e.g. drug near-misses, professional regulation), and alternative spellings for each synonym (e.g. medication, medications)
• Deciding whether systematic reviews (the subject of Article 7) or single research studies are the focus of the search [8], and
• Providing any additional details that limit the search (e.g. children, adults)
The second set of steps includes:
• Choosing those words and phrases that would all need to be present in order for the article to be identified (e.g. medication error, systematic 
review, and children), connecting them with ‘and’, and putting them in brackets, and
• Choosing those words and phrases for which only one would need to be present (e.g. medical error and its synonyms), connecting them with ‘or’, 
and putting them in brackets, and
• Connecting both sets of brackets using ‘and’
The third set of steps includes:
• Using the Internet to access the health-related database, PubMed. This database contains a ‘hedge’ (i.e. a validated search strategy or filter) for the 
types of studies of interest here [12]
• Clicking on ‘special queries’ in the left task bar
• Clicking on ‘health services research’ queries
• Entering the words and phrases, as well as the Boolean operators (‘and’/‘or’) in the search field, and
• Clicking ‘process assessment’ or ‘outcomes assessment’ for administrative database studies and ‘qualitative research’ for qualitative studies
This approach increases the chances that the returned citations will be of the appropriate study type, though many other types of studies may be 
retrieved as well.Health Research Policy and Systems 2009, 7(Suppl 1):S4 http://www.health-policy-systems.com/content/7/S1/S4
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‘soft’ indicators such as self-reported health status. Partic-
ular groups may be motivated only by indicators from the
health sector, such as health-related quality of life. Other
groups, in contrast, may be motivated by indicators from
non-health sectors that can have an influence on health
and healthcare, such as employment status. The impor-
tance of comparisons can also vary by group, with some
groups more interested in a narrowly defined group of
peers that share a range of key characteristics (such as large
university-affiliated teaching hospitals), and others more
interested in the full spectrum of organisations providing
similar types of healthcare (such as all hospitals).
Qualitative research can shed light on the meanings that
individuals or groups attach to a particular problem, the
indicators used to measure it, and the comparisons made
to establish its importance. Table 3 provides tips for find-
ing this type of research. Conversations with different
groups and available qualitative research can help policy-
makers identify which framings of a problem (or pur-
pose) can best mobilise support among different groups
to address a problem. A key challenge, however, is ensur-
ing that the alternative framings being considered are con-
sistent with the problem, as determined through the type
of systematic analysis described above.
Conclusion
Problem clarification can all too easily be skipped over
entirely, or else done too rapidly, or in too cursory a way.
It may also not be done iteratively when additional data
and research evidence are found regarding indicators and
comparisons, or when policies and programmes encoun-
ter challenges or fail to yield results. Any such failures in
problem clarification may mean that further resource
investments based on existing conceptions of a problem
will be misguided. Close attention should be paid there-
fore to indicators, comparisons and alternative framings
to ensure that decisions about which particular problem
to focus on are well-informed. The process of clarifying a
problem will influence decisions about which particular
options warrant serious consideration based on how they
address a problem.
Resources
Useful documents and further reading
- Kingdon JW: Agendas, Alternatives, and Public Policies,
2 edn. New York, USA: Longman; 2003, pp. 90-115.
- Rosenhead J, Mingers J (Eds): Rational Analysis for a
Problematic World Revisited:. Problem Structuring Meth-
ods for Complexity, Uncertainty and Conflict. Chichester,
UK: John Wiley & Sons Ltd.; 2001; pp 61-2.
- Stone D: Policy Paradox: The Art of Political Decision
Making. New York: W. W. Norton and Company;
1997.
- Sweeney K. Griffiths F (Eds). Complexity and Health-
care. An Introduction. Oxford, UK: Radcliffe Medical
Press; 2002, pp. 100.
Links to websites
- Program in Policy Decision-Making (PPD)/Canadian
Cochrane Network and Centre (CCNC) database:
http://www.researchtopolicy.ca/search/reviews.aspx –
Source of a taxonomy of governance, financial and
delivery arrangements within health systems where
problems may be located, as well as systematic reviews
of administrative database studies, community sur-
veys, and qualitative research addressing health sys-
tem arrangements
PubMed Health Services Research (HSR) Queries: 
http://www.nlm.nih.gov/nichsr/hedges/search.html –
Source of ‘hedges’(i.e. validated search strategies) to
identify administrative database studies and commu-
nity surveys that can help to put a problem in compar-
ative perspective and to identify qualitative studies
that can help to frame problem in ways that resonate
with different stakeholders
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